Folgen
Erik Cederfjäll
Erik Cederfjäll
Bestätigte E-Mail-Adresse bei abbvie.com
Titel
Zitiert von
Zitiert von
Jahr
Regulation of cerebral cortex folding by controlling neuronal migration via FLRT adhesion molecules
D Del Toro, T Ruff, E Cederfjäll, A Villalba, G Seyit-Bremer, V Borrell, ...
Cell 169 (4), 621-635. e16, 2017
1332017
Optimized adeno-associated viral vector-mediated striatal DOPA delivery restores sensorimotor function and prevents dyskinesias in a model of advanced Parkinson’s disease
T Björklund, T Carlsson, EA Cederfjäll, M Carta, D Kirik
Brain 133 (2), 496-511, 2010
592010
Gene therapy for Parkinson's disease: disease modification by GDNF family of ligands
D Kirik, E Cederfjäll, G Halliday, Å Petersén
Neurobiology of disease 97, 179-188, 2017
542017
Design of a single AAV vector for coexpression of TH and GCH1 to establish continuous DOPA synthesis in a rat model of Parkinson's disease
E Cederfjäll, G Sahin, D Kirik, T Björklund
Molecular Therapy 20 (7), 1315-1326, 2012
452012
Continuous DOPA synthesis from a single AAV: dosing and efficacy in models of Parkinson's disease
E Cederfjäll, N Nilsson, G Sahin, Y Chu, E Nikitidou, T Björklund, ...
Scientific reports 3 (1), 2157, 2013
352013
Controlled striatal DOPA production from a gene delivery system in a rodent model of Parkinson's disease
E Cederfjäll, L Broom, D Kirik
Molecular Therapy 23 (5), 896-906, 2015
282015
Gene therapy for dopamine replacement
T Björklund, EA Cederfjäll, D Kirik
Progress in brain research 184, 220-235, 2010
142010
Key factors determining the efficacy of gene therapy for continuous DOPA delivery in the Parkinsonian brain
E Cederfjäll, G Sahin, D Kirik
Neurobiology of disease 48 (2), 222-227, 2012
122012
Reduced baseline sensitivity to maraviroc inhibition among R5 HIV-1 isolates from individuals with severe immunodeficiency
U Karlsson, J Repits, L Antonsson, E Cederfjäll, B Ljungberg, M Ålenius, ...
JAIDS Journal of Acquired Immune Deficiency Syndromes 71 (3), e79-e82, 2016
52016
GENE EXPRESSION SYSTEM AND REGULATION THEREOF
D KIRIK, E CEDERFJÄLL
2019
Gene expression system and regulation thereof
D Kirik, E Cederfjäll
US Patent App. 15/300,686, 2017
2017
Novel strategies for enzyme replacement with gene therapy in models of Parkinson’s disease
E Cederfjäll
Lund University Faculty of Medicine Doctoral Dissertation Series 2014 (47), 2014
2014
Das System kann den Vorgang jetzt nicht ausführen. Versuchen Sie es später erneut.
Artikel 1–12